Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digoxin-diltiazem interaction: a pharmacokinetic evaluation.

W N Jones, K B Kern, J P Rindone

    European Journal of Clinical Pharmacology
    |January 1, 1986
    PubMed
    Summary

    This study found no significant pharmacokinetic interaction between digoxin and diltiazem in healthy volunteers. Digoxin elimination rate, volume of distribution, and clearance remained unchanged after a two-week diltiazem course.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Coronary angiographic findings for out-of-hospital cardiac arrest survivors presenting with nonshockable rhythms and no ST elevation post resuscitation.

    Resuscitation·2022
    Same author

    A local neighborhood volunteer network improves response times for simulated cardiac arrest.

    Resuscitation·2019
    Same author

    Over 675,000 lay people trained in cardiopulmonary resuscitation worldwide - The "World Restart a Heart (WRAH)" initiative 2018.

    Resuscitation·2019
    Same author

    Interventional Cardiologist Approach to Cardiac Arrest.

    Current cardiology reviews·2018
    Same author

    "All citizens of the world can save a life" - The World Restart a Heart (WRAH) initiative starts in 2018.

    Resuscitation·2018
    Same author

    Letters.

    Journal of wound care·2016

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy

    Background:

    • Digoxin is a cardiac glycoside used for heart failure and arrhythmias.
    • Diltiazem is a calcium channel blocker commonly prescribed for cardiovascular conditions.
    • Potential drug interactions between digoxin and diltiazem require investigation due to their overlapping patient populations.

    Purpose of the Study:

    • To evaluate the pharmacokinetic interaction between digoxin and diltiazem.
    • To determine if diltiazem alters the absorption, distribution, metabolism, or excretion of digoxin.

    Main Methods:

    • A pharmacokinetic study was conducted in 7 healthy volunteers.
    • Intravenous digoxin doses were administered before and after a 2-week course of diltiazem (30 mg four times daily).
    • Key pharmacokinetic parameters including elimination rate, volume of distribution, and total body clearance were measured.

    Related Experiment Videos

    Main Results:

    • No significant differences were observed in the terminal elimination rate constants (0.0231 vs. 0.0254 h-1).
    • Volumes of distribution (10.5 vs. 10.2 L/kg) and total body clearances (3.72 vs. 4.09 mL/min/kg) of digoxin did not change significantly.
    • Individual pharmacokinetic parameters of digoxin remained consistent before and during diltiazem administration.

    Conclusions:

    • Diltiazem does not appear to significantly alter the pharmacokinetics of digoxin.
    • There is no clinically significant drug interaction between digoxin and diltiazem based on this study.
    • Concomitant use of these medications in healthy individuals may be considered safe from a pharmacokinetic perspective.